Response to Comments: MolDX-CDD: Decipher® Prostate Cancer Classifier Assay

This document is an administrative response-to-comments notice for MolDX-CDD: Decipher® Prostate Cancer Classifier Assay, recording the comment period (06/22/2016–08/08/2016), notice period (08/25/2016–10/09/2016), and LCD effective date (10/10/2016). The provided text contains no clinical coverage criteria, indications, limitations, documentation requirements, or frequency limits. Clinical coverage criteria and claim requirements should be obtained from the final LCD or associated policy documents for this assay.